PepGen Inc. Faces Class Action for Securities Fraud: Key Information for Investors
PepGen Inc. Faces Securities Fraud Class Action
Overview
PepGen Inc. is currently facing a class action securities lawsuit, and investors are encouraged to stay informed about their potential rights and options. The legal proceedings have been initiated by Levi & Korsinsky, LLP, known for their expertise in such high-stakes litigation. The lawsuit specifically addresses claims of securities fraud that allegedly took place between March 7, 2024, and March 3, 2025.
Key Details of the Class Action
The class action has been designed to represent investors who may have suffered losses during the specified time due to misleading information provided by the company regarding its lead product candidate, PGN-EDO51. According to the filed complaint, several critical assertions were made by PepGen’s management:
1. The efficacy and safety of PGN-EDO51 were overstated, leading investors to believe it was more effective than it actually was.
2. The CONNECT2 study, which is crucial for FDA approval, was allegedly conducted in a manner that involved safety risks and deficiencies that were not disclosed.
3. Due to these issues, there was a significant risk that the study would be halted altogether and that the commercial prospects for PGN-EDO51 were not accurately represented to investors.
4. These inaccurate representations led to materially misleading statements from the company throughout the period in question.
What Investors Should Do
Investors who believe they have lost money due to these alleged actions should take action before the August 8, 2025 deadline. They are welcome to contact Levi & Korsinsky to discuss their situation and the possibility of being appointed as lead plaintiff. Importantly, one does not need to serve as a lead plaintiff to be eligible for recovery, ensuring access to remedies for a broader range of affected parties.
The firm assures that participating in the class does not involve any out-of-pocket fees, making it accessible to those impacted by the potential fraud. Investors can find more detailed information through the provided links or by reaching out directly to the legal team.
Why Choose Levi & Korsinsky
Boasting over two decades of successful litigation, Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders. They have established a solid reputation in complex securities litigation and are recognized as one of the leading firms in the United States, being featured in ISS Securities Class Action Services' Top 50 Report for seven consecutive years. This track record should instill confidence in potential class members looking for reliable legal representation.
Contact Information
Those who wish to know more or take part in the legal action can contact:
- - Joseph E. Levi, Esq.
- - Ed Korsinsky, Esq.
New York, NY 10004
Email: [email protected]
Phone: (212) 363-7500
Fax: (212) 363-7171
Conclusion
The class action lawsuit against PepGen Inc. highlights significant concerns about transparency and trust in corporate communications. As this situation unfolds, it's crucial for affected investors to understand their rights and the steps they can take to seek redress. Staying informed and taking timely action could be key to addressing these alleged infractions effectively.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.